References
- Tan EM. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93–151
- Isenberg D, Smeenk R. Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now?. Lupus 2002; 11: 797–800
- Kavanaugh AF, Solomon DH. American college of rheumatology ad hoc committee on immunologic testing guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti-DNA antibody tests. Arthritis Rheum 2002; 47: 546–555
- Donald F, Ward MM. Evaluative laboratory testing practices of United States rheumatologists. Arthritis Rheum 1998; 41: 725–729
- Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277
- Reveille JD. Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 2004; 13: 290–297
- Hanh BH. Antibodies to DNA. N Engl J Med 1998; 338: 1359–1368
- Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset activity of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526–1533
- Sinico RA, Bollini B, Sabadini E, Di Toma L, Radice A. The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus. J Nephrol 2002; 15(6)20–27
- Rahman A, Hiepe F. Anti-DNA antibodies—overview of assays and clinical correlations. Lupus 2002; 11: 770–773
- Bootsma H, Spronk P, Derksen R, et al. Prevention of relapses in systemic lupus erythematosus. Lancet 1995; 345: 1595–1599
- Emlen W, Jarusiripipat P, Burdick G. A new ELISA for the detection of double-stranded DNA antibodies. J Immunol Methods 1990; 132: 91–101
- Hylkema MN, Huygen H, Kramers C, et al. Clinical evaluation of a modified ELISA, using photobiotinylated DNA, for the detection of anti-DNA antibodies. J Immunol Methods 1994; 170: 93–102
- Haugbro K, Nossent JC, Winkler T, Figenschau Y, Rekvig OP. Anti-dsDNA antibodies and disease classification in antinuclear positive patients: The role of analytical diversity. Ann Rheum Dis 2004; 63: 386–394
- Deng JS, Sontheimer RD, Lipscomb MF, Gilliam JN. The binding of anti-histone antibodies to Crithidia luciliae kinetoplast is growth cycle-dependent. Arthritis Rheum 1985; 28: 163–168
- Sinico RA. Interdisciplinary forum on autoimmune disease research: Guidelines. G Ital Nefrol 2002; 19(2)212–224
- Pisetsky DS, Reich CF. The influence of DNA size on the binding of anti-DNA antibodies in the solid and fluid phase. Clin Immunol Immunopathol 1994; 72(3)350–356
- Herrmann M, Winkler TH, Fehr H, Kalden JR. Preferential recognition of specific DNA motifs by anti-double-stranded DNA autoantibodies. Eur J Immunol 1995; 25: 1897–1904
- Pisetsky DS, Gonzalez TC. The influence of DNA size on the binding of antibodies to DNA in the sera of normal human subjects and patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1999; 116: 354–359
- Stollar BD. Molecular analysis of anti-DNA antibodies. FASEB J 1994; 8: 337–342
- Wallace DJ, Salonen EM, Avaniss-Aghajani E, Morris R, Metzger AL, Pashinia N. Anti-telomere antibodies in systemic lupus erythematosus: A new ELISA test for anti-DNA with potential pathogenetic implications. Lupus 2000; 9: 328–332
- Salonen EM, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H. Anti-telomere antibodies in systemic lupus erythematosus (SLE): A comparison with five antinuclear antibodies assays in 430 patients with SLE and other rheumatic diseases. Ann Rheum Dis 2004; 63: 1250–1254